Partial Compliance as Determined From Plasma Levels of Sertraline and Its Metabolite in Depressed Patients in Primary CareREIS, Margareta; AKERBLAD, Ann-Charlotte; EKSELIUS, Lisa et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 6, pp 746-748, issn 0271-0749, 3 p.Article

Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitionersAKERBLAD, Ann-Charlotte; BENGTSSON, Finn; EKSELIUS, Lisa et al.International clinical psychopharmacology. 2003, Vol 18, Num 6, pp 347-354, issn 0268-1315, 8 p.Article

Sertraline versus paroxetine in major depression : Clinical outcome after six months of continuous therapyABERG-WISTEDT, Anna; AGREN, Hans; EKSELIUS, Lisa et al.Journal of clinical psychopharmacology. 2000, Vol 20, Num 6, pp 645-652, issn 0271-0749Article

Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrationsREIS, Margareta; ABERG-WISTEDT, Anna; AGREN, Hans et al.Journal of affective disorders. 2004, Vol 82, Num 3, pp 443-446, issn 0165-0327, 4 p.Article

Overall and cause-specific mortality in GH-deficient adults on GH replacementGAILLARD, Rolf C; MATTSSON, Anders F; ABS, Roger et al.European journal of endocrinology. 2012, Vol 166, Num 6, pp 1069-1077, issn 0804-4643, 9 p.Article